Insider · CIK 0001874017
Cearley Cassia
Reports to the SEC for 1 company · SEATTLE, WA
Transactions
31
Companies
1
Filings
12
CIK
0001874017
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2024-02-19 | Icosavax, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2024-02-19 | Icosavax, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2024-02-19 | Icosavax, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2024-02-19 | Icosavax, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2024-02-19 | Icosavax, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2024-02-19 | Icosavax, Inc.U Disposition from Tender | — |
| 2024-02-19 | Icosavax, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2024-02-19 | Icosavax, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-12-20 | Icosavax, Inc.S Sale | −$123K |
| 2023-12-13 | Icosavax, Inc.S Sale | −$140K |
| 2023-07-31 | Icosavax, Inc.S Sale | −$16.7K |
| 2023-05-23 | Icosavax, Inc.S Sale | −$100K |
| 2023-03-06 | Icosavax, Inc.S Sale | −$38.7K |
| 2023-02-15 | Icosavax, Inc.Stock Option (Right to Buy)A Award | — |
| 2023-02-13 | Icosavax, Inc.S Sale | −$17.7K |
| 2023-01-30 | Icosavax, Inc.M Exercise/Conversion | +$21.1K |
| 2023-01-30 | Icosavax, Inc.Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2022-11-10 | Icosavax, Inc.Stock Option (Right to Buy)A Award | — |
| 2022-08-02 | Icosavax, Inc.S Sale | −$2,031.251 |
| 2022-08-01 | Icosavax, Inc.S Sale | −$7,420.613 |
| 2022-07-29 | Icosavax, Inc.S Sale | −$2,779.072 |
| 2022-05-31 | Icosavax, Inc.A Award | +$9,618.59 |
| 2022-03-18 | Icosavax, Inc.M Exercise/Conversion | +$29.5K |
| 2022-03-18 | Icosavax, Inc.Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2022-03-07 | Icosavax, Inc.S Sale | −$163K |
| 2022-03-07 | Icosavax, Inc.S Sale | −$8,620.04 |
| 2022-02-10 | Icosavax, Inc.Stock Option (Right to Buy)A Award | — |
| 2022-02-10 | Icosavax, Inc.A Award | — |
| 2021-11-15 | Icosavax, Inc.Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2021-11-15 | Icosavax, Inc.M Exercise/Conversion | +$18.8K |
| 2021-07-30 | Icosavax, Inc.A Award | +$416K |
Recent filings
- 4Cearley Cassia0000950170-24-017419SEC(opens sec.gov)
- 4Cearley Cassia0001209191-23-059617SEC(opens sec.gov)
- 4Cearley Cassia0001209191-23-058890SEC(opens sec.gov)
- 4Cearley Cassia0001209191-23-044079SEC(opens sec.gov)
- 4Cearley Cassia0001209191-23-032313SEC(opens sec.gov)
- 4Cearley Cassia0001209191-23-017292SEC(opens sec.gov)
- 4Cearley Cassia0001209191-23-010900SEC(opens sec.gov)
- 4Cearley Cassia0001209191-23-009907SEC(opens sec.gov)
- 5Cearley Cassia0001209191-23-009215SEC(opens sec.gov)
- 4Cearley Cassia0001209191-23-005695SEC(opens sec.gov)
- 4Cearley Cassia0001209191-22-056820SEC(opens sec.gov)
- 4Cearley Cassia0001209191-22-044015SEC(opens sec.gov)
Companies
Address
C/O ICOSAVAX, INC. 1616 EASTLAKE AVENUE E., SUITE 208
SEATTLE, WA, 98102